Stock data
Cytosorbents Corporation (CTSO)
Cytosorbents Corporation (CTSO) reported net income of -US$8.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | US$26.49M | -US$14.75M | -US$8.20M | — |
| 2024 | — | US$24.89M | -US$16.45M | -US$20.72M | — |
| 2023 | — | US$21.95M | -US$31.95M | -US$29.25M | — |
| 2022 | — | US$20.73M | -US$31.52M | -US$32.81M | — |
| 2021 | — | US$32.12M | -US$22.74M | -US$24.56M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$9.63M | -US$4.42M | — |
| 2026-03-31 | — | -US$5.13M | — |
| 2025-12-31 | — | -US$5.50M | — |
| 2025-09-30 | — | -US$3.17M | — |
| 2025-06-30 | US$9.62M | US$1.95M | — |
| 2025-03-31 | — | -US$1.48M | — |
| 2024-12-31 | — | -US$7.57M | — |
| 2024-09-30 | — | -US$2.77M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.